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OA candidate genes including 50 kb of ﬂanking sequence to either
side were obtained from Ensembl. Autosomal SNPs with minor allele
frequency (MAF) in Europeans >5% and mapping to these sequences
were extracted from HapMap. Fixed effect meta-analysis across 8 OA
GWAS was performed for these SNPs. Signiﬁcance threshold was set
after Bonferroni correction for the effective number of independent test
determined with the simpleM method.
Fig. 1.
Results: A total of 186 OA candidate genes including 24298 SNPs were
analyzed in GWAS results from 5630 subjects with knee OA, 5180
with hip OA and 31272 controls. This allowed 0.8 power to detect
association of a SNP with O.R. = 1.14 and 0.2 MAF at the P < 2.2
×10−5 signiﬁcance threshold calculated for this study. Nine SNPs in the
7q22 OA locus were signiﬁcantly associated with knee OA. The most
highly associated SNP in this locus, rs4730250, has already shown GWAS
level signiﬁcant association in a previous study. There were also seven
COL11A1 SNPs associated with hip OA. They represent, at least, two
independent association signals suggesting the presence of multiple
causal polymorphisms in this gene (labelled in blue and in red in
Figure 1).
Gender stratiﬁed analyses showed association of 17 SNPs in GDF5 (top
SNP rs224329, P =1.2×10−5) with knee OA in females and of rs833058 in
VEGF with hip OA in males (P = 1.3×10−5).
Conclusions: We have found that only a small fraction of OA candidate
genes were conﬁrmed in our meta-analysis, which is the largest done to
date. This is a common ﬁnding in complex diseases. Two of the loci, 7q22
and GDF5, were already widely recognized as truthfully involved in OA
and our analysis did not identify new signals in them. The other two loci
were not renowned in genetics. However, they are particularly interesting
because of the functional implications of VEGF , which is well known
for promoting angiogenesis, and for the possibility of multiple causal
polymorphisms in COL11A1, which codes for one of the chains of type XI
collagen that is involved in maintaining cartilage integrity and cohesion.
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Purpose: As mesenchymal stem cells (MSCs) differentiate they undergo
epigenetic changes. We hypothesized that elucidation of changes such as
alterations in DNA methylation would lead to increased understanding of
differentiation along speciﬁc lineages. DNA methylation is an epigenetic
process whereby methyl groups are added to cytosine residues (CpG)
typically resulting in reduced gene expression. The aim of this project
was to investigate global changes in gene promoter methylation patterns
as MSCs differentiated down various lineages and thereby identify
differentially methylated genes associated with speciﬁc differentiation
pathways.
Methods: Genomic DNA was extracted from undifferentiated,
chondrogenic, osteogenic and adipogenic MSCs at 14 days and analysed
for changes in promoter methylation patterns using a high throughput
epigenomic discovery platform with custom CpG island arrays (Inﬁnium
Human Methylation 27BeadChip Assay). 28K CpG probes were used to
analyze gene promoter regions of 14K genes yielding beta values ranging
from 0–1 depending on level of promoter methylation (0=unmethylated,
1=methylated). Stringent selection criteria were applied to the data
generated to select genes for further study. RNA was extracted from
undifferentiated and differentiated MSCs at 0, 2, 4, 7 and 14 days and
quantitative RT-PCR performed to validate array results and investigate
temporal gene expression levels of selected targets. Protein levels were
determined by Western Blotting or ELISA.
Fig. 1. (A) Heat map of representative genes illustrating relative
hypomethylation of undifferentiated MSC promoter regions in
comparison to differentiated MSCs. Scatter plots showing clustering of
undifferentiated MSC methylation patterns to those of (B) chondrocytes,
(C) osteocytes and (D) adipocytes.
Results: Analysis of the methylation patterns indicated that promoters
of undifferentiated MSCs were generally hypomethylated in agreement
with the comparatively unrestricted gene expression of these cells
(Figure 1A). Chondro- and osteo-differentiated MSC clustered closer
than to undifferentiated MSC or to adipogenic progeny, with the latter
two groups showing the least similarity (Figure 1B-D). Lineage-speciﬁc,
differentially methylated genes were selected to create differentiation-
speciﬁc methylation signatures for validation by qRT-PCR and bisulphite
sequencing. This analysis showed that DNA methylation contributed
to the rapid down regulation of superﬂuous genes on commitment
to a speciﬁc lineage whereas hypomethylation of speciﬁc CpGs was
associated with upregulation of genes associated with the differentiation
process. Based the stringent selection criteria, 15 genes (9 chondro-,
4 adipo- and 2 osteo-speciﬁc) were selected for array validation and
further study. Of the chondrogenic genes chosen, 8 were hypomethylated
following differentiation and one hypermethylated. Five of the genes
showed changes in gene expression corresponding to their methylation
signature. Of the four validated hypomethylated genes, MIA/CD-RAP and
SCRG1 have been previously associated with chondrogenesis whereas
Interleukin 16 (IL16) was identiﬁed as a novel hypomethylated factor in
chondrogenesis of MSCs. Expression of this cytokine mimicked that of
CD-RAP increasing expression over the ﬁrst 7 days of chondrogenesis
and thereafter decreasing; gene expression was rapidly downregulated
on differentiation to the adipo- and osteo- lineages. IL16 protein was
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detected in chondrogenic pellets and secreted by the differentiating
MSCs. Finally, high levels of IL16 were detected in osteoarthritic
cartilage.
Conclusions: We hypothesise that differentiation of MSCs initially
involves hypermethylation to facilitate the rapid down regulatation of
genes involved in self-renewal or alternative differentiation pathways.
Epigenetic mechanisms also represent an important aspect of control
to ensure the sequential and temporal expression of critical genes
throughout the differentiation process. IL16, previously associated with
synovial ﬁbroblasts from rheumatoid joints was identiﬁed as a novel
factor in chondrogenesis.
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Purpose: Exercise is regarded a cornerstone in the treatment of mild to
moderate osteoarthritis (OA). However, little is known of the effects in
patients with advanced and end-stage OA. The purpose was to evaluate
the effect of neuromuscular exercise in patients with severe hip OA.
Methods: Design. Randomized controlled trial (Clinicaltrials.gov
identiﬁer: NCT01003756). 84 patients, 51% female, mean age
68.6±7.8 years, BMI 28.7±4.7 scheduled for total hip replacement at
Svendborg Community Hospital, Odense University Hospital, Denmark
were included. Intervention. Participants were randomized to an eight-
week neuromuscular exercise (NEMEX-TJR) intervention or care-as-
usual (verbal and written preoperative information). Intervention was
supervised and offered twice a week with each session lasting one
hour. The program is considered feasible and safe in this patient
group and previously described in detail. Assessments were carried
out at baseline and within one week after the intervention. Outcomes.
Functional performance: 20-m walk at maximal pace and 5 repeated
chair stands timed. Muscle power: Unilateral multi-joint leg extension
power and unilateral single-joint knee extension power evaluated with
a leg extension press (Nottingham Power Rig, Nottingham University,
Nottingham, UK) and a seated knee extension machine (Oemmebi,
Moglia, Italy) adapted with a linear encoder (MuscleLab Power, Ergotest
Technology, Langesund, Norway), respectively.
Results: On average the intervention group attended 13±4 sessions
(Table 1). In favor of the intervention group, the between-group
difference was signiﬁcant for 20-m walk (2.2 seconds, p = 0.009), chair
stands (1.7 seconds, p = 0.022) and leg extension for the non operated
leg (.17 W/kg, p = 0.049) (Table 2).
Table 1. Baseline characteristics of study participants
Exercise intervention Care-as-usual
Scheduled for operation – no. 43 41
Female sex – no. (%) 22 (51) 21 (51)
Age – yr 68.7 [66.1;71.3] 68.6 [66.3;70.8]
BMI – kg m−2 28.5 [27.3;29.7] 28.8 [27.1;30.5]
Exercise sessions – no. 13 [12.2;14.7] −
Table 2. Baseline values and change over time (mean ± SD)
Outcome measure Baseline Change
Exercise
intervention
Care-as-
usual
Exercise
intervention
Care-as-
usual
Between-group
mean difference
p-value
Muscle power (Wkg−1)
Multi-joint leg extension
Non operated 1.28
[1.11;1.45]
1.33
[1.12;1.54]
0.22
[0.09;0.35]
0.05
[−.05;0.16]
0.17 0.049
Operated 1.02
[0.85;1.20]
1.09 [0.9;1.3] 0.07
[−0.07;0.20]
−0.05
[−0.18;0.08]
0.12 0.200
Single-joint knee extension
Non operated 0.82
[0.67;0.96]
0.81
[0.65;0.97]
0.10
[0.05;0.16]
−0.01
[−0.14;0.11]
0.12 0.091
Operated 0.59
[0.47;0.72
0.58
[0.42;0.74
0.08
[0.01;0.14]
0.10
[−0.07;0.27]
0.03 0.761
Functional performance (s)
Chair stands 13.1
[11.5;14.7]
13.4
[11.9;14.9]
−2.7
[−3.9;-1.4]
−0.5
[−1.6;0.7]
2.2 0.009
20-m max pace 15.2
[13.6;16.8]
15.6
[14.1;17.1]
−1.0
[−1.8;-.1]
0.7 [−0.5;1.9] 1.7 0.022
Conclusion: Eight weeks neuromuscular exercise according to the
NEMEX-TJR program improves functional performance and leg extension
power in patients with severe OA of the hip joint.
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Purpose: The purpose of the study was to evaluate time to total hip
replacement (THR) surgery in patients with hip osteoarthritis going
through both a supervised exercise program and patient education
(SE+PE) compared to patients going through patient education only (PE).
Methods: One hundred and nine patients were included in the study
between April 2005 and October 2007. Inclusion criteria were age
40–80 years, hip pain for three months or more, radiographically
veriﬁed hip osteoarthritis (Danielson’s criteria), and Harris Hip Score
between 60–95 points, i.e. their impairments were not severe enough
for considering THR at time of inclusion. All patients initially had three
sessions of patient education. After completing the education program
baseline assessments were conducted, and the patients were then
randomized to 1) a 12 week supervised exercise program (SE+PE, n = 55),
or 2) no further treatment (PE, n = 54). Both groups were recommended
to follow the information giving during the patient education. The
SE+PE group performed exercises 2–3 times weekly supervised by a
physical therapist. The exercises consisted of strength training, functional
exercises, and ﬂexibility exercises.
Between April 12th and May 3rd 2011, 3.5 to 6 years after inclusion, all
patients were contacted by telephone and information on whether and
when THR surgery had been performed were collected. Survival analysis
(Kaplan-Maier) were used to assess time to THR surgery in both groups.
Group differences were tested by the Log Rank test.
Results: Twelve patients (11%) did not respond at latest follow-up
(April/May 2011). Six of these patients had previously informed us that
they had gone through THR surgery and at what time, and the remaining
six patients were censored.
In total, 53 (48.6%) patients went through THR surgery within the follow-
up time, 22 (40.0%) in the SE+PE group and 31 (57.4%) in the PE group.
Median time to THR surgery was 1953 days (95% conﬁdence interval
(CI): 1634, 2272) and 1260 days (95% CI: 850, 1670) in the PE group.
Cumulative survival without THR surgery after 6 years was 41.4% in the
SE+PE group and 25.4% in the SE group (Figure 1, p = 0.034).
Fig. 1. Kaplan–Meier plot. Cumulative survival (without THR surgery) in
the SE+PE group (green line) and the PE group (blue line). Censored data
is marked at each line.
